Acute management of paroxysmal supraventricular tachycardia: Verapamil, adenosine triphosphate or adenosine?
- 1 July 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 54 (1) , 225-227
- https://doi.org/10.1016/0002-9149(84)90334-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation, 1983
- Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate, and verapamil: a comparative study.Circulation, 1982
- The clinical use of intravenous verapamilAmerican Heart Journal, 1980
- Intravenous Verapamil for Termination of Re-Entrant Supraventricular TachycardiasAnnals of Internal Medicine, 1980
- Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.Circulation, 1980
- New perspectives in the pharmacologic therapy of cardiac arrhythmiasProgress in Cardiovascular Diseases, 1980
- Effect of verapamil in infants with paroxysmal supraventricular tachycardia.Circulation, 1979
- Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.Heart, 1977
- Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogramAmerican Heart Journal, 1975
- Verapamil in the treatment of paroxysmal supraventricular tachycardiaPostgraduate Medical Journal, 1974